Prevalence of Autoimmune Disease Among Patients With Lung Cancer: Implications for Immunotherapy Treatment Options

被引：121

作者：

Khan, Saad A. ^{[1
,2
]}

Pruitt, Sandi L. ^{[2
,3
]}

Xuan, Lei ^{[3
]}

Gerber, David E. ^{[1
,2
]}

机构：

[1] Univ Texas Southwestern Med Ctr Dallas, Div Hematol & Oncol, Dallas, TX USA

[2] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA

[3] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX USA

来源：

JAMA ONCOLOGY | 2016年 / 2卷 / 11期

关键词：

IPILIMUMAB; MELANOMA;

D O I：

10.1001/jamaoncol.2016.2238

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1507 / 1508

页数：3

共 3 条

[1] Risks of myeloid malignancies in patients with autoimmune conditions [J].

Anderson, L. A. ;

Pfeiffer, R. M. ;

Landgren, O. ;

Gadalla, S. ;

Berndt, S. I. ;

Engels, E. A. .

BRITISH JOURNAL OF CANCER, 2009, 100 (05) :822-828

[2] Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders [J].

Johnson, Douglas B. ;

Sullivan, Ryan J. ;

Ott, Patrick A. ;

Carlino, Matteo S. ;

Khushalani, Nikhil I. ;

Ye, Fei ;

Guminski, Alexander ;

Puzanov, Igor ;

Lawrence, Donald P. ;

Buchbinder, Elizabeth I. ;

Mudigonda, Tejaswi ;

Spencer, Kristen ;

Bender, Carolin ;

Lee, Jenny ;

Kaufman, Howard L. ;

Menzies, Alexander M. ;

Hassel, Jessica C. ;

Mehnert, Janice M. ;

Sosman, Jeffrey A. ;

Long, Georgina V. ;

Clark, Joseph I. .

JAMA ONCOLOGY, 2016, 2 (02) :234-240

[3] Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma [J].

Postow, Michael A. ;

Chesney, Jason ;

Pavlick, Anna C. ;

Robert, Caroline ;

Grossmann, Kenneth ;

McDermott, David ;

Linette, Gerald P. ;

Meyer, Nicolas ;

Giguere, Jeffrey K. ;

Agarwala, Sanjiv S. ;

Shaheen, Montaser ;

Ernstoff, Marc S. ;

Minor, David ;

Salama, April K. ;

Taylor, Matthew ;

Ott, Patrick A. ;

Rollin, Linda M. ;

Horak, Christine ;

Gagnier, Paul ;

Wolchok, Jedd D. ;

Hodi, F. Stephen .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21) :2006-2017

← 1 →